Jennifer L. Huntington

FDA investigator

Appears on 31 documents from 2015 to 2023, mostly at sites in Florida. Most often cites production record review (21 CFR 211.192).

31
Documents on file
6.6
Observations per 483
2015
First seen
2023
Most recent

What they cite most

From 206 observations

Activity by year

2015: 1, 2016: 1, 2017: 3, 2018: 10, 2019: 10, 2020: 2, 2021: 2, 2023: 2

Where

Florida 22 · India 4 · Arkansas 1 · Georgia 1 · Tennessee 1 · United Kingdom 1

Is Jennifer L. Huntington coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

31 documents, newest first
FirmOpen
483 Aurobindo Pharma LimitedSep 29, 2023 · Sangareddy, India
483 Hetero Labs LimitedSep 21, 2023 · Mahabubnagar, India
483 Norbrook Laboratories LimitedOct 15, 2021 · Newry, United Kingdom
Amended 483 Actavis Laboratories FL, Inc.May 25, 2021 · Davie, Florida
483 Intas Pharmaceuticals LimitedFeb 28, 2020 · Ahmedabad, India
483 Infusion Systems of SW Florida Inc. dbaFeb 9, 2020 · Fort Myers, Florida
483 Transdermal Delivery Solutions Corp, dbaDec 3, 2019 · Palm Beach Gardens, Florida

About this profile

What does Jennifer L. Huntington inspect?

Jennifer L. Huntington appears on 31 documents on file covering 29 sites, mostly in Florida.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.113 and FDCA 501(a)(2)(A).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jennifer L. Huntington is dated Sep 29, 2023.